| 1 |
32970933 | Efficacy of cabazitaxel and the influence of clinical factors on the overall survival of patients with castration-resistant prostate cancer: A local experience of a multicenter retrospective study. | 2021 Jun |
1 |
| 2 |
33904646 | Post Hoc Health-Related Quality of Life Analysis According to Response Among Patients with Prostate Cancer in the PROSELICA and FIRSTANA Studies. | 2021 Jul |
1 |
| 3 |
34110449 | Serum and hematologic responses after three cycles of cabazitaxel therapy as predictors of survival in castration-resistant prostate cancer. | 2021 Sep |
2 |
| 4 |
34219125 | Long-Term Prostate-Specific Antigen Response on a Low-Dose Cabazitaxel Regimen for Metastatic Castration-Resistant Prostate Cancer: A Case Report. | 2021 Jul 5 |
1 |
| 5 |
34450475 | Baseline neutrophil-to-lymphocyte ratio as a predictive and prognostic biomarker in patients with metastatic castration-resistant prostate cancer treated with cabazitaxel versus abiraterone or enzalutamide in the CARD study. | 2021 Oct |
1 |
| 6 |
31892584 | Prognostic Impact of Prior Androgen Receptor Axis-targeting Agents in Cabazitaxel Chemotherapy After Docetaxel. | 2020 Jan |
1 |
| 7 |
31931827 | Aggressive prostate cancer with somatic loss of the homologous recombination repair gene FANCA: a case report. | 2020 Jan 13 |
1 |
| 8 |
31185946 | Complete response with early introduction of cabazitaxel in a patient with multiple lung metastases of castration-resistant prostate cancer following the early detection of metastases using liquid biopsy: a case report. | 2019 Jun 11 |
1 |
| 9 |
31361807 | Safety and efficacy of cabazitaxel in 660 patients with metastatic castration-resistant prostate cancer in real-world settings: results of a Japanese post-marketing surveillance study. | 2019 Dec 27 |
1 |
| 10 |
31369101 | Prostate-specific antigen response patterns during cabazitaxel therapy in patients with metastatic castration-resistant prostate cancer. | 2019 Dec 18 |
1 |
| 11 |
31461725 | Correlation between Automated Bone Scan Index Change after Cabazitaxel and Survival among Men with Castration-Resistant Prostate Cancer. | 2019 |
1 |
| 12 |
31570485 | Risk Factors for Poor Survival in Metastatic Castration-resistant Prostate Cancer Treated With Cabazitaxel in Japan. | 2019 Oct |
2 |
| 13 |
29305637 | PSA response to cabazitaxel is associated with improved progression-free survival in metastatic castration-resistant prostate cancer: the non-interventional QoLiTime study. | 2018 Mar |
4 |
| 14 |
29636272 | Efficacy of cabazitaxel rechallenge in heavily treated patients with metastatic castration-resistant prostate cancer. | 2018 Jul |
1 |
| 15 |
30283980 | No significant impact of patient age and prior treatment profile with docetaxel on the efficacy of cabazitaxel in patient with castration-resistant prostate cancer. | 2018 Dec |
4 |
| 16 |
27618249 | Quality of life and pain relief in men with metastatic castration-resistant prostate cancer on cabazitaxel: the non-interventional 'QoLiTime' study. | 2017 May |
1 |
| 17 |
27960186 | Cabazitaxel in Metastatic Castration-Resistant Prostate Cancer Patients Progressing after Docetaxel: A Prospective Single-Center Study. | 2017 |
1 |
| 18 |
26829012 | Severe neutropenia during cabazitaxel treatment is associated with survival benefit in men with metastatic castration-resistant prostate cancer (mCRPC): A post-hoc analysis of the TROPIC phase III trial. | 2016 Mar |
1 |
| 19 |
27057826 | Docetaxel Rechallenge in a Heavily Pretreated Patient With Castration-Resistant Prostate Cancer: A Case Report and Review of Literature. | 2016 Apr |
3 |
| 20 |
24255983 | Enzalutamide treatment in patients with metastatic castration-resistant prostate cancer progressing after chemotherapy and abiraterone acetate. | 2014 Jun |
1 |
| 21 |
24411987 | Activity of cabazitaxel in castration-resistant prostate cancer progressing after docetaxel and next-generation endocrine agents. | 2014 Sep |
1 |
| 22 |
24725337 | Prostate-specific antigen flare induced by cabazitaxel-based chemotherapy in patients with metastatic castration-resistant prostate cancer. | 2014 Jun |
1 |
| 23 |
23532557 | Cabazitaxel: a guide to its use in hormone-refractory metastatic prostate cancer. | 2013 May |
3 |
| 24 |
22445962 | Cabazitaxel rechallenge at prostate-specific antigen relapse after previous cabazitaxel and docetaxel chemotherapy: case report. | 2012 Sep |
1 |
| 25 |
22933996 | Sequencing of cabazitaxel in metastatic castrate-resistant prostate cancer: a case report. | 2012 May |
2 |